Modular Medical to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025
Modular Medical (NASDAQ:MODD), a company specializing in insulin delivery technology, has announced its participation in the upcoming Lytham Partners Spring 2025 Investor Conference on May 29, 2025. The virtual event will feature a webcast presentation at 11:00 a.m. ET, which will be accessible through the conference website and available for replay afterward.
CEO Jeb Besser will conduct one-on-one meetings with investors throughout the conference. The company, known for developing the first FDA-cleared patch pump specifically designed for adult "almost-pumpers" with user-friendly and affordable features, invites interested parties to arrange meetings through Lytham Partners.
Modular Medical (NASDAQ:MODD), azienda specializzata nella tecnologia per la somministrazione di insulina, ha annunciato la sua partecipazione alla prossima Conferenza Investitori Lytham Partners Primavera 2025 che si terrà il 29 maggio 2025. L'evento virtuale prevede una presentazione in webcast alle 11:00 ET, accessibile tramite il sito web della conferenza e disponibile in seguito per la visione on demand.
Il CEO Jeb Besser terrà incontri individuali con gli investitori durante tutta la conferenza. L'azienda, nota per aver sviluppato il primo patch pump approvato dalla FDA progettato specificamente per adulti "quasi-pumpers" con caratteristiche semplici da usare e a prezzi accessibili, invita gli interessati a fissare appuntamenti tramite Lytham Partners.
Modular Medical (NASDAQ:MODD), una empresa especializada en tecnología para la administración de insulina, ha anunciado su participación en la próxima Conferencia de Inversores Lytham Partners Primavera 2025 el 29 de mayo de 2025. El evento virtual incluirá una presentación por webcast a las 11:00 a.m. ET, accesible a través del sitio web de la conferencia y disponible para reproducción posterior.
El CEO Jeb Besser realizará reuniones individuales con inversores durante toda la conferencia. La empresa, reconocida por desarrollar la primera bomba en parche aprobada por la FDA diseñada específicamente para adultos "casi usuarios de bomba" con características fáciles de usar y asequibles, invita a los interesados a concertar reuniones a través de Lytham Partners.
Modular Medical (NASDAQ:MODD)은 인슐린 전달 기술을 전문으로 하는 회사로, 다가오는 2025년 봄 Lytham Partners 투자자 컨퍼런스에 2025년 5월 29일 참여할 것이라고 발표했습니다. 이 가상 행사는 오전 11시(동부 시간)에 웹캐스트 프레젠테이션이 진행되며, 컨퍼런스 웹사이트를 통해 시청 가능하며 이후 재생도 가능합니다.
CEO Jeb Besser는 컨퍼런스 기간 동안 투자자들과 일대일 미팅을 진행할 예정입니다. 사용자 친화적이고 합리적인 가격의 성인 "거의 펌프 사용자"를 위해 특별히 설계된 FDA 승인 첫 패치 펌프를 개발한 회사로서, 관심 있는 분들은 Lytham Partners를 통해 미팅을 예약할 수 있습니다.
Modular Medical (NASDAQ:MODD), une entreprise spécialisée dans la technologie de délivrance d'insuline, a annoncé sa participation à la prochaine Conférence des investisseurs Lytham Partners Printemps 2025 le 29 mai 2025. L'événement virtuel comprendra une présentation en webcast à 11h00 ET, accessible via le site web de la conférence et disponible en replay par la suite.
Le PDG Jeb Besser tiendra des réunions individuelles avec les investisseurs tout au long de la conférence. L'entreprise, reconnue pour avoir développé la première pompe patch approuvée par la FDA, spécialement conçue pour les adultes "presque utilisateurs de pompe" avec des fonctionnalités conviviales et abordables, invite les intéressés à organiser des rendez-vous via Lytham Partners.
Modular Medical (NASDAQ:MODD), ein Unternehmen, das sich auf Insulinabgabetechnologie spezialisiert hat, hat seine Teilnahme an der bevorstehenden Lytham Partners Frühjahr 2025 Investorenkonferenz am 29. Mai 2025 angekündigt. Die virtuelle Veranstaltung beinhaltet eine Webcast-Präsentation um 11:00 Uhr ET, die über die Konferenz-Website zugänglich ist und anschließend als Aufzeichnung verfügbar sein wird.
CEO Jeb Besser wird während der gesamten Konferenz Einzelgespräche mit Investoren führen. Das Unternehmen, bekannt für die Entwicklung der ersten von der FDA zugelassenen Patch-Pumpe, die speziell für erwachsene "Fast-Pump-Anwender" mit benutzerfreundlichen und erschwinglichen Merkmalen entwickelt wurde, lädt Interessenten ein, Termine über Lytham Partners zu vereinbaren.
- None.
- None.
SAN DIEGO, CA / ACCESS Newswire / May 22, 2025 / Modular Medical, Inc. (NASDAQ:MODD) ("Modular Medical" or the "Company"), an insulin delivery technology company with the first FDA-cleared patch pump designed specifically to target all adult "almost-pumpers" with its user-friendly and affordable design, today announced it will participate in a webcast presentation and host one-on-one meetings with investors at the Lytham Partners Spring 2025 Investor Conference, taking place virtually, on Thursday, May 29, 2025.
Company Webcast
The webcast presentation will take place at 11:00 a.m. ET on Thursday, May 29, 2025. The webcast can be accessed by visiting the conference home page at https://lythampartners.com/spring2025/ or directly at https://app.webinar.net/Zyr70D402Aj. The webcast will also be available for replay following the event.
1x1 Meetings
Jeb Besser, the Company's Chief Executive Officer, will host virtual one-on-one meetings throughout the event. To arrange a meeting with Mr. Besser, please contact Lytham Partners at 1x1@lythampartners.com or register for the event at https://lythampartners.com/spring2025invreg/.
About Modular Medical
Modular Medical, Inc. (NASDAQ:MODD) is a medical device company that intends to launch the next generation of insulin delivery technology. Using its patented technologies, the Company seeks to eliminate the tradeoff between complexity and efficacy, thereby making top quality insulin delivery both affordable and simple to learn. Its mission is to improve access to the highest standard of glycemic control for people with diabetes taking it beyond "superusers" and providing "diabetes care for the rest of us."
Modular Medical was founded by Paul DiPerna, a seasoned medical device professional and microfluidics engineer. Prior to founding Modular Medical, Mr. DiPerna was the founder (in 2005) of Tandem Diabetes and invented and designed its t:slim insulin pump. More information is available at https://modular-medical.com.
All trademarks mentioned herein are the property of their respective owners.
CONTACT:
Jeb Besser
Chief Executive Officer
Modular Medical, Inc.
+1 (617) 399-1741
IR@modular-medical.com
SOURCE: Modular Medical, Inc.
View the original press release on ACCESS Newswire
FAQ
When is Modular Medical (MODD) presenting at the Lytham Partners Spring 2025 Conference?
How can investors attend MODD's presentation at the Lytham Partners Conference?
Who is presenting for Modular Medical at the Lytham Partners Conference?
How can investors schedule one-on-one meetings with MODD's management?
